Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

Dicerna Pharmaceuticals, Inc. (DRNA)

-NasdaqGS
14.90 Down 0.88(5.58%) 4:00PM EDT
Prev Close:15.78
Open:15.86
Bid:14.76 x 200
Ask:15.45 x 2000
1y Target Est:40.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:14.83 - 15.89
52wk Range:14.76 - 46.00
Volume:135,087
Avg Vol (3m):154,422
Market Cap:264.67M
P/E (ttm):N/A
EPS (ttm):-9.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DRNA

Comparison

Symbol% ChgMkt Cap
DRNADown 5.58%264.67M
AMGNUp 0.20%92.55B
BAYRYUp 0.25%112.27B
TKMRDown 2.15%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.27
Quarterly EPS Est (Jun-14) :-0.47
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback